Amrutanjan Health Care Ltd. | Small-cap | Healthcare
₹718.25
0.56%
| Amrutanjan Health Stock Comparison:
Amrutanjan Health vs Sun PharmaceuticalAmrutanjan Health vs Divi's LaboratoriesAmrutanjan Health vs Suven Life SciencesAmrutanjan Health vs Sequent ScientificAmrutanjan Health vs Aarti DrugsAmrutanjan Health vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 940.5M
Gross Profit 446.6M 47.48%
Operating Income 69.2M 7.35%
Net Income 83.1M 8.84%
EPS (Diluted) ₹2.87

Balance Sheet Metrics

Total Assets 4.2B
Total Liabilities 947.7M
Shareholders Equity 3.3B
Debt to Equity 0.29

Cash Flow Metrics

Revenue & Profitability Trend

Amrutanjan Health Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i4.5B4.2B3.8B4.0B3.3B
Cost of Goods Sold i2.2B2.1B1.8B1.8B1.4B
Gross Profit i2.3B2.1B2.0B2.2B1.9B
Gross Margin % i50.5%49.6%51.9%55.4%57.8%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i820.4M786.9M771.7M756.6M580.3M
Other Operating Expenses i205.2M222.6M185.8M96.6M52.0M
Total Operating Expenses i1.0B1.0B957.4M853.3M632.3M
Operating Income i535.7M480.2M420.6M819.7M795.0M
Operating Margin % i11.9%11.4%11.1%20.3%23.9%
Non-Operating Items
Interest Income i160.5M148.0M117.8M111.7M93.9M
Interest Expense i2.2M1.6M771.0K4.8M5.0M
Other Non-Operating Income-----
Pre-tax Income i691.3M619.5M536.5M905.8M819.0M
Income Tax i183.0M169.7M138.1M233.9M207.1M
Effective Tax Rate % i26.5%27.4%25.7%25.8%25.3%
Net Income i508.3M449.7M398.3M671.9M611.9M
Net Margin % i11.3%10.7%10.5%16.6%18.4%
Key Metrics
EBITDA i760.8M689.2M591.8M970.3M939.7M
EPS (Basic) i₹17.58₹15.50₹13.65₹23.00₹20.94
EPS (Diluted) i₹17.58₹15.50₹13.63₹22.98₹20.93
Basic Shares Outstanding i2891063029019920291783982920760929221922
Diluted Shares Outstanding i2891063029019920291783982920760929221922

Income Statement Trend

Amrutanjan Health Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i803.8M257.6M675.6M834.8M1.3B
Short-term Investments i1.1B1.8B1.2B1.2B446.4M
Accounts Receivable i558.2M478.9M330.2M382.6M176.6M
Inventory i272.6M289.0M288.3M260.0M174.6M
Other Current Assets82.6M75.7M51.4M50.5M38.2M
Total Current Assets i2.9B3.0B2.6B2.7B2.2B
Non-Current Assets
Property, Plant & Equipment i41.9M27.2M24.0M17.7M7.4M
Goodwill i17.3M23.8M24.8M23.2M15.1M
Intangible Assets i17.3M23.8M24.8M23.2M15.1M
Long-term Investments-----
Other Non-Current Assets176.5M17.1M15.4M19.2M-100.0K
Total Non-Current Assets i1.3B711.9M1.0B752.2M513.7M
Total Assets i4.2B3.7B3.6B3.5B2.7B
Liabilities
Current Liabilities
Accounts Payable i690.4M558.6M474.4M604.5M406.7M
Short-term Debt i4.0M3.3M5.1M5.7M6.4M
Current Portion of Long-term Debt-----
Other Current Liabilities94.5M84.0M78.5M65.0M48.6M
Total Current Liabilities i845.8M699.2M630.1M774.7M521.0M
Non-Current Liabilities
Long-term Debt i16.8M14.0M4.0M3.1M7.0M
Deferred Tax Liabilities i-----
Other Non-Current Liabilities-----
Total Non-Current Liabilities i101.9M84.6M83.1M72.7M66.0M
Total Liabilities i947.7M783.8M713.2M847.4M587.1M
Equity
Common Stock i28.9M28.9M29.2M29.2M29.2M
Retained Earnings i2.7B2.4B2.4B2.1B1.6B
Treasury Stock i10.6M16.2M44.6M45.0M9.6M
Other Equity-----
Total Shareholders Equity i3.3B2.9B2.9B2.7B2.2B
Key Metrics
Total Debt i20.8M17.3M9.1M8.8M13.4M
Working Capital i2.1B2.3B2.0B2.0B1.7B

Balance Sheet Composition

Amrutanjan Health Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i691.3M619.5M536.5M905.8M819.0M
Depreciation & Amortization i-----
Stock-Based Compensation i11.4M2.2M4.4M-113.0K6.2M
Working Capital Changes i-62.4M-191.9M8.4M-287.9M209.6M
Operating Cash Flow i482.1M282.8M432.2M510.9M945.9M
Investing Activities
Capital Expenditures i-355.5M-64.6M-88.8M-234.6M-18.7M
Acquisitions i-----
Investment Purchases i-114.6M--123.2M-302.1M-915.3M
Investment Sales i5.0K115.0M75.0M48.2M0
Investing Cash Flow i-470.1M50.4M-137.1M-488.5M-934.0M
Financing Activities
Share Repurchases i0-288.0M0--9.6M
Dividends Paid i-132.7M-133.9M-144.1M-124.8M-57.8M
Debt Issuance i-----
Debt Repayment i-----
Financing Cash Flow i-130.3M-477.1M-144.1M-160.1M-86.8M
Free Cash Flow i153.5M211.9M112.5M287.3M889.1M
Net Change in Cash i-118.4M-143.8M151.0M-137.6M-74.8M

Cash Flow Trend

Amrutanjan Health Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 37.88
Price to Book 6.32
Price to Sales 4.47
PEG Ratio 0.48

Profitability Ratios

Profit Margin 11.80%
Operating Margin 7.36%
Return on Equity 15.56%
Return on Assets 12.06%

Financial Health

Current Ratio 3.44
Debt to Equity 0.64
Beta 0.39

Per Share Data

EPS (TTM) ₹18.86
Book Value per Share ₹112.98
Revenue per Share ₹159.74

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
amrutanjan21.2B37.886.3215.56%11.80%0.64
Sun Pharmaceutical 3.9T36.745.3015.08%19.29%3.26
Divi's Laboratories 1.6T65.3610.0914.64%23.89%0.03
Suven Life Sciences 48.2B-28.0140.49-146.15%84.44%0.00
Sequent Scientific 48.1B166.336.612.84%1.85%62.47
Aarti Drugs 44.5B23.663.2612.28%7.80%44.92

Financial data is updated regularly. All figures are in the company's reporting currency.